Pre-Open Stock Movers 04/06: (TUFN) (BTAI) (TLRY) Higher; (CANO) (CAR) (JBLU) Lower (more...)

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. QCOM
2. CBRS
3. FDX
4. USO
5. MU
6. SPY
7. KBH
8. HTZ
9. HON
10. JPM

Go back to Pre-Open Stock Movers 04/06: (TUFN) (BTAI) (TLRY) Higher; (CANO) (CAR) (JBLU) Lower (more...)

BioXcel Therapeutics (BTAI) PT Raised to $84 at Canaccord Genuity

April 7, 2022 7:56 AM EDT

Canaccord Genuity analyst Sumant Kulkarni raised the price target on BioXcel Therapeutics (NASDAQ: BTAI) to $84.00 (from $81.00) while maintaining a Buy rating.

The analyst commented, "Earlier today (4/6), BTAI announced that the FDA approved Igalmi (BXCL501, dexmedetomidine film) for the acute treatment of agitation in patients with schizophrenia or bipolar disorder. We had earlier characterized approval as a... More

BioXcel Therapeutics (BTAI) PT Raised to $76 at Jefferies

April 6, 2022 11:40 AM EDT

Jefferies analyst Chris Howerton raised the price target on BioXcel Therapeutics (NASDAQ: BTAI) to $76.00 (from $73.00) while maintaining a Buy rating on FDA Approval of IGALMI Sublingual Film.

The analyst noted the label was broad, pricing is soon, and trade-launch in Q3.

... More

Tilray (TLRY) PT Raised to $8.40 at Cantor Fitzgerald

April 6, 2022 10:41 AM EDT

Cantor Fitzgerald analyst Pablo Zuanic raised the price target on Tilray (NASDAQ: TLRY) to $8.40 (from $6.90) while maintaining a Neutral rating following results and the recent re-rate higher on U.S. news flow.

The analyst commented, "We think the main takeaway from this... More